uploads/2016/06/Part-5-Graph-06-06-16-1-1.png

IBB Holdings: How Are Their Moving Averages Trending?

By

Updated

IBB’s moving averages

The iShares Nasdaq Biotechnology ETF (IBB) has 189 stocks in its portfolio. As of June 6, 2016, 87% of IBB’s stocks were trading above their 20-day moving averages, 71% were trading above their 50-day moving averages, and 74% were trading above their 100-day moving averages.

This is a drastic jump compared to the moving averages as of May 31, 2016. That day, 17% were trading above their 20-day moving averages, 35% were trading above their 50-day moving averages, and 41% were trading above their 100-day moving averages.

Article continues below advertisement

The above graph shows the percentage of IBB’s holdings that were trading at various moving averages on June 6, 2016. Of IBB’s 189 stocks, 165 were trading above their 20-day moving averages, 135 were trading above their 50-day moving averages, and 139 were trading above their 100-day moving averages.

What’s IBB’s moving average trend?

On June 6, 2016, IBB closed at $286.07 and was trading above its 20-day, 50-day, and 100-day moving averages. As of that day, IBB’s 20-day moving average was $267.10. On May 31, 2016, its 20-day moving average was $263.30, indicating an upward trend.

Article continues below advertisement

A few IBB stocks are trading above their 20-day and 100-day moving averages

Alnylam Pharmaceuticals (ALNY), Seattle Genetics (SGEN), Qiagen (QGEN), and Juno Therapeutics (JUNO) are a few of IBB’s 165 stocks that are trading above their 20-day moving averages as of June 6, 2016. Let’s also see how these stocks are trending at their 100-day moving average compared to the average on May 31, 2016.

IBB stocks trading above their 20-day moving averages

  • Alnylam: $58.30 as of May 31, 2016; $61 as of June 6, 2016
  • Seattle Genetics: $36.40 as of May 31, 2016; $38.20 as of June 6, 2016
  • Qiagen: $21.60 as of May 31, 2016; $21.70 as of June 6, 2016
  • Juno Therapeutics: $39.20 as of May 31, 2016; $40.60 as of June 6, 2016

All four stocks showed an upward trend.

IBB stocks trading above their 100-day moving averages

  • Alnylam: $64.60 as of May 31, 2016; $64.10 as of June 6, 2016
  • Seattle Genetics: $34.80 as of May 31, 2016; $35 as of June 6, 2016
  • Qiagen: $22.10 as of May 31, 2016; $22 as of June 6, 2016
  • Juno Therapeutics: $37.30 as of May 31, 2016; $37.50 as of June 6, 2016

Alnylam and Qiagen showed a downward trend, while Seattle Genetics and Juno Therapeutics showed an upward trend.

Moving averages help investors identify price trends and compare stocks’ current prices with various moving average prices. This can help you identify support and resistance levels and make informed investment decisions.

Advertisement

More From Market Realist